Johnson Health Tech .Co., Ltd.

TWSE:1736 Rapport sur les actions

Capitalisation boursière : NT$38.9b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Johnson Health Tech .Co Croissance future

Future contrôle des critères 3/6

Johnson Health Tech .Co devrait augmenter ses bénéfices et ses revenus de 15.2% et de 2.8% par an respectivement, tandis que le BPA devrait croître de croître de 15.1% par an.

Informations clés

30.4%

Taux de croissance des bénéfices

30.3%

Taux de croissance du BPA

Leisure croissance des bénéfices26.1%
Taux de croissance des recettes3.5%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour22 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Johnson Health Tech .Co., Ltd.'s (TWSE:1736) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Jul 16
Johnson Health Tech .Co., Ltd.'s (TWSE:1736) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Investors Appear Satisfied With Johnson Health Tech .Co., Ltd.'s (TWSE:1736) Prospects As Shares Rocket 32%

May 08
Investors Appear Satisfied With Johnson Health Tech .Co., Ltd.'s (TWSE:1736) Prospects As Shares Rocket 32%

Does Johnson Health Tech .Co (TWSE:1736) Have A Healthy Balance Sheet?

Apr 09
Does Johnson Health Tech .Co (TWSE:1736) Have A Healthy Balance Sheet?

The Strong Earnings Posted By Johnson Health Tech .Co (TWSE:1736) Are A Good Indication Of The Strength Of The Business

Mar 23
The Strong Earnings Posted By Johnson Health Tech .Co (TWSE:1736) Are A Good Indication Of The Strength Of The Business

Johnson Health Tech .Co (TWSE:1736) Shareholders Will Want The ROCE Trajectory To Continue

Mar 06
Johnson Health Tech .Co (TWSE:1736) Shareholders Will Want The ROCE Trajectory To Continue

These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Extensively

Apr 26
These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Extensively

Investors Met With Slowing Returns on Capital At Johnson Health Tech (TPE:1736)

Mar 27
Investors Met With Slowing Returns on Capital At Johnson Health Tech (TPE:1736)

Did You Miss Johnson Health Tech's (TPE:1736) Impressive 180% Share Price Gain?

Feb 25
Did You Miss Johnson Health Tech's (TPE:1736) Impressive 180% Share Price Gain?

Should Johnson Health Tech. Co., Ltd. (TPE:1736) Focus On Improving This Fundamental Metric?

Feb 10
Should Johnson Health Tech. Co., Ltd. (TPE:1736) Focus On Improving This Fundamental Metric?

These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Reasonably Well

Jan 26
These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Reasonably Well

Do Institutions Own Johnson Health Tech. Co., Ltd. (TPE:1736) Shares?

Jan 11
Do Institutions Own Johnson Health Tech. Co., Ltd. (TPE:1736) Shares?

Returns On Capital At Johnson Health Tech (TPE:1736) Paint An Interesting Picture

Dec 27
Returns On Capital At Johnson Health Tech (TPE:1736) Paint An Interesting Picture

The Johnson Health Tech (TPE:1736) Share Price Has Gained 144%, So Why Not Pay It Some Attention?

Nov 27
The Johnson Health Tech (TPE:1736) Share Price Has Gained 144%, So Why Not Pay It Some Attention?

Prévisions de croissance des bénéfices et des revenus

TWSE:1736 - Estimations futures des analystes et données financières antérieures (TWD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202542,9701,8542,3642,9951
12/31/202442,3431,4071,3352,0252
6/30/202440,7321,1773,1643,932N/A
3/31/202439,0601,2194,1174,948N/A
12/31/202338,0707103,1353,843N/A
9/30/202336,8385901,9892,404N/A
6/30/202335,19144428465N/A
3/31/202333,122-300-632-291N/A
12/31/202233,613429-48392N/A
9/30/202231,863369-1,071-238N/A
6/30/202231,052-361-1,469-651N/A
3/31/202231,03653-3,659-2,818N/A
12/31/202130,77938-4,295-3,537N/A
9/30/202130,76553-3,341-2,681N/A
6/30/202131,0241,011-1,542-798N/A
3/31/202130,1029991,2792,005N/A
12/31/202028,3676792,1072,942N/A
9/30/202026,9018941,8182,563N/A
6/30/202025,5847841,6802,409N/A
3/31/202025,5701,015176990N/A
12/31/201925,3731,293234943N/A
9/30/201924,4601,12974695N/A
6/30/201923,708979-56591N/A
3/31/201922,6096127431,337N/A
12/31/201821,757390348981N/A
9/30/201820,769189131956N/A
6/30/201820,00967245954N/A
3/31/201819,540-6N/A13N/A
12/31/201719,494130N/A-74N/A
9/30/201719,477358N/A-939N/A
6/30/201719,958453N/A-215N/A
3/31/201720,191716N/A818N/A
12/31/201620,165716N/A1,258N/A
9/30/201619,659710N/A2,014N/A
6/30/201618,764769N/A282N/A
3/31/201617,963563N/A-154N/A
12/31/201516,975564N/A-217N/A
9/30/201516,5201,940N/A-813N/A
6/30/201516,3451,976N/A703N/A
3/31/201516,3132,296N/A2,482N/A
12/31/201416,5512,638N/A1,851N/A
9/30/201416,2621,477N/A2,232N/A
6/30/201415,9391,366N/A1,642N/A
3/31/201415,4161,058N/A398N/A
12/31/201315,071857N/A773N/A
9/30/201315,231542N/A575N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de 1736 ( 15.2% par an) est supérieure au taux d'épargne ( 1% ).

Bénéfices vs marché: Les bénéfices de 1736 ( 30.4% par an) devraient croître plus rapidement que le marché TW ( 18.8% par an).

Croissance élevée des bénéfices: Les bénéfices de 1736 devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de 1736 ( 2.8% par an) devrait croître plus lentement que le marché de TW ( 11.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de 1736 ( 2.8% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de 1736 devrait être élevé dans 3 ans


Découvrir les entreprises en croissance